249 related articles for article (PubMed ID: 24806303)
1. FGFR1 mutations in Rosette-forming glioneuronal tumors of the fourth ventricle.
Gessi M; Moneim YA; Hammes J; Goschzik T; Scholz M; Denkhaus D; Waha A; Pietsch T
J Neuropathol Exp Neurol; 2014 Jun; 73(6):580-4. PubMed ID: 24806303
[TBL] [Abstract][Full Text] [Related]
2. Analysis of KIAA1549-BRAF fusion status in a case of rosette-forming glioneuronal tumor of the fourth ventricle (RGNT).
Gessi M; Waha A; Setty P; Waha A; Pietsch T
Neuropathology; 2011 Dec; 31(6):654-7. PubMed ID: 21518014
[TBL] [Abstract][Full Text] [Related]
3. Absence of KIAA1549-BRAF fusion in rosette-forming glioneuronal tumors of the fourth ventricle (RGNT).
Gessi M; Lambert SR; Lauriola L; Waha A; Collins VP; Pietsch T
J Neurooncol; 2012 Oct; 110(1):21-5. PubMed ID: 22814862
[TBL] [Abstract][Full Text] [Related]
4. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.
Becker AP; Scapulatempo-Neto C; Carloni AC; Paulino A; Sheren J; Aisner DL; Musselwhite E; Clara C; Machado HR; Oliveira RS; Neder L; Varella-Garcia M; Reis RM
J Neuropathol Exp Neurol; 2015 Jul; 74(7):743-54. PubMed ID: 26083571
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor.
Lucas CG; Gupta R; Doo P; Lee JC; Cadwell CR; Ramani B; Hofmann JW; Sloan EA; Kleinschmidt-DeMasters BK; Lee HS; Wood MD; Grafe M; Born D; Vogel H; Salamat S; Puccetti D; Scharnhorst D; Samuel D; Cooney T; Cham E; Jin LW; Khatib Z; Maher O; Chamyan G; Brathwaite C; Bannykh S; Mueller S; Kline CN; Banerjee A; Reddy A; Taylor JW; Clarke JL; Oberheim Bush NA; Butowski N; Gupta N; Auguste KI; Sun PP; Roland JL; Raffel C; Aghi MK; Theodosopoulos P; Chang E; Hervey-Jumper S; Phillips JJ; Pekmezci M; Bollen AW; Tihan T; Chang S; Berger MS; Perry A; Solomon DA
Acta Neuropathol Commun; 2020 Aug; 8(1):151. PubMed ID: 32859279
[TBL] [Abstract][Full Text] [Related]
6. Rosette-forming glioneuronal tumor: a pineal region case with IDH1 and IDH2 mutation analyses and literature review of 43 cases.
Solis OE; Mehta RI; Lai A; Mehta RI; Farchoukh LO; Green RM; Cheng JC; Natarajan S; Vinters HV; Cloughesy T; Yong WH
J Neurooncol; 2011 May; 102(3):477-84. PubMed ID: 20872044
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive analysis of 41 patients with rosette-forming glioneuronal tumors of the fourth ventricle.
Zhang J; Babu R; McLendon RE; Friedman AH; Adamson C
J Clin Neurosci; 2013 Mar; 20(3):335-41. PubMed ID: 23375398
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive genetic characterization of rosette-forming glioneuronal tumors: independent component analysis by tissue microdissection.
Kitamura Y; Komori T; Shibuya M; Ohara K; Saito Y; Hayashi S; Sasaki A; Nakagawa E; Tomio R; Kakita A; Nakatsukasa M; Yoshida K; Sasaki H
Brain Pathol; 2018 Jan; 28(1):87-93. PubMed ID: 27893178
[TBL] [Abstract][Full Text] [Related]
9. Rosette-forming glioneuronal tumor of the fourth ventricle.
Preusser M; Dietrich W; Czech T; Prayer D; Budka H; Hainfellner JA
Acta Neuropathol; 2003 Nov; 106(5):506-8. PubMed ID: 12915951
[TBL] [Abstract][Full Text] [Related]
10. Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1.
Sievers P; Appay R; Schrimpf D; Stichel D; Reuss DE; Wefers AK; Reinhardt A; Coras R; Ruf VC; Schmid S; de Stricker K; Boldt HB; Kristensen BW; Petersen JK; Ulhøi BP; Gardberg M; Aronica E; Hasselblatt M; Brück W; Bielle F; Mokhtari K; Lhermitte B; Wick W; Herold-Mende C; Hänggi D; Brandner S; Giangaspero F; Capper D; Rushing E; Wesseling P; Pfister SM; Figarella-Branger D; von Deimling A; Sahm F; Jones DTW
Acta Neuropathol; 2019 Sep; 138(3):497-504. PubMed ID: 31250151
[TBL] [Abstract][Full Text] [Related]
11. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
[TBL] [Abstract][Full Text] [Related]
12. Rosette-forming glioneuronal tumor of the fourth ventricle with bilateral olivary degeneration.
Fushimi Y; Miyasaki A; Taki H; Aoyama K; Hirato J; Kanagaki M; Togashi K
Jpn J Radiol; 2011 Jul; 29(6):445-8. PubMed ID: 21786101
[TBL] [Abstract][Full Text] [Related]
13. Imaging features of rosette-forming glioneuronal tumours (RGNTs): A Series of seven cases.
Medhi G; Prasad C; Saini J; Pendharkar H; Bhat MD; Pandey P; Muthane Y
Eur Radiol; 2016 Jan; 26(1):262-70. PubMed ID: 26017735
[TBL] [Abstract][Full Text] [Related]
14. Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients.
Ishi Y; Yamaguchi S; Hatanaka KC; Okamoto M; Motegi H; Kobayashi H; Terasaka S; Houkin K
J Neurosurg; 2020 Feb; 134(3):733-741. PubMed ID: 32059187
[TBL] [Abstract][Full Text] [Related]
15. An epilepsy-associated glioneuronal tumor with mixed morphology harboring FGFR1 mutation.
Yamada S; Nobusawa S; Yamazaki T; Teranishi T; Watanabe S; Murayama K; Ohba S; Okabe A; Sakurai K; Urano M; Tsukamoto T; Yokoo H; Hirose Y; Abe M
Pathol Int; 2019 Jun; 69(6):372-377. PubMed ID: 31218776
[TBL] [Abstract][Full Text] [Related]
16. Synchronous rosette-forming glioneuronal tumor and diffuse astrocytoma with molecular characterization: a case report.
Cachia D; Prado MP; Theeler B; Hamilton J; McCutcheon I; Fuller GN
Clin Neuropathol; 2014; 33(6):407-11. PubMed ID: 24986181
[TBL] [Abstract][Full Text] [Related]
17. Rosette-forming glioneuronal tumour: imaging features, histopathological correlation and a comprehensive review of literature.
Hsu C; Kwan G; Lau Q; Bhuta S
Br J Neurosurg; 2012 Oct; 26(5):668-73. PubMed ID: 22512825
[TBL] [Abstract][Full Text] [Related]
18. Rosette-forming glioneuronal tumor of the fourth ventricle with advanced microvascular proliferation--a case report.
Matyja E; Grajkowska W; Nauman P; Ozieblo A; Bonicki W
Neuropathology; 2011 Aug; 31(4):427-32. PubMed ID: 21092064
[TBL] [Abstract][Full Text] [Related]
19. Rosette-forming glioneuronal tumor of the fourth ventricle: report of two cases with a differential diagnostic overview.
Vajtai I; Arnold M; Kappeler A; Jeless O; Lukes A; Mariani L; Paulus W
Pathol Res Pract; 2007; 203(8):613-9. PubMed ID: 17651910
[TBL] [Abstract][Full Text] [Related]
20. Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors.
Fina F; Barets D; Colin C; Bouvier C; Padovani L; Nanni-Metellus I; Ouafik L; Scavarda D; Korshunov A; Jones DT; Figarella-Branger D
Oncotarget; 2017 Jan; 8(2):2104-2113. PubMed ID: 27791984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
